Current status of antivascular therapy and targeted treatment in the clinic

International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Olav DahlOystein Fluge

Abstract

Antivascular and targeted therapy are now an integrated part of the treatment of myelogenous leukemias, GIST tumours, B-cell lymphomas and breast cancer. In various malignancies improved responses and prolongation of survival for several months is regularly reported. The progress in this field is relevant for hyperthermia. Heat has among other effects documented antivascular effects, and can be considered as one of the established methods in the field based on several randomised phase III studies. Hyperthermia should be considered for combination with other antiangiogenic agents.

References

May 1, 1991·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·H LyngE K Rofstad
Mar 1, 1972·Annals of Surgery·J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Jan 1, 1984·Acta Radiologica. Oncology·J Denekamp
Feb 1, 1983·European Journal of Cancer & Clinical Oncology·J DenekampB Hobson
Dec 1, 1981·International Journal of Radiation Oncology, Biology, Physics·E K Rofstad, T Brustad
May 1, 1994·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·L F Fajardo, S D Prionas
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S A HillD J Chaplin
Jan 1, 1996·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J OvergaardS M Bentzen
Mar 1, 1997·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·S N HornslethP Raskmark
Jul 1, 1997·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J W HandJ B Whaley
Feb 11, 1998·International Journal of Radiation Oncology, Biology, Physics·P K SneedP H Gutin
Jan 29, 1999·Journal of the National Cancer Institute·P le CoutreC Gambacorti-Passerini
Aug 24, 1999·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·S KanamoriM Hiraoka
Nov 26, 1999·International Journal of Radiation Oncology, Biology, Physics·L R ProsnitzD M Brizel
Jan 5, 2000·The Journal of Clinical Investigation·B J Druker, N B Lydon
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Feb 7, 2001·Journal of the National Cancer Institute·M Hidalgo, S G Eckhardt
Mar 17, 2001·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Y HarimaS Sawada
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Apr 5, 2001·The New England Journal of Medicine·J M Goldman, J V Melo
Jun 13, 2001·JAMA : the Journal of the American Medical Association·J Stephenson
Jul 6, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H P EikesdalO Dahl
Jul 27, 2001·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·P D MaguireM W Dewhirst
Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·H P EikesdalO Dahl
Jan 25, 2002·The New England Journal of Medicine·Bruce D Cheson
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Mar 21, 2002·The Lancet Oncology·G Gasparini
Mar 26, 2002·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·H P EikesdalO Dahl
Jul 31, 2002·The Lancet Oncology·P WustP M Schlag
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold F Dvorak
Nov 5, 2002·Nature Reviews. Cancer·Shahin RafiiBeate Heissig
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz KabbinavarEmily Bergsland
Jun 5, 2003·Nature Medicine·Christopher W Pugh, Peter J Ratcliffe
Jun 5, 2003·Nature Medicine·Donald M McDonald, Peter L Choyke

❮ Previous
Next ❯

Citations

Mar 19, 2009·Acta Oncologica·Olav Dahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
R A Burger
Expert Opinion on Biological Therapy
Matteo MorottiSimone Ferrero
Current Opinion in Oncology
Lakshmi Balasubramanian, Andrew M Evens
Biologics : Targets & Therapy
Amalia MilanoFrancesco Caponigro
The Breast : Official Journal of the European Society of Mastology
Mirna H FarhatAli I Shamseddine
© 2021 Meta ULC. All rights reserved